Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
46.80
-0.16 (-0.34%)
At close: Oct 7, 2025, 4:00 PM EDT
46.64
-0.16 (-0.34%)
Pre-market: Oct 8, 2025, 6:11 AM EDT
Qiagen Revenue
Qiagen had revenue of $533.54M in the quarter ending June 30, 2025, with 7.49% growth. This brings the company's revenue in the last twelve months to $2.04B, up 5.15% year-over-year. In the year 2024, Qiagen had annual revenue of $1.98B with 0.66% growth.
Revenue (ttm)
$2.04B
Revenue Growth
+5.15%
P/S Ratio
4.97
Revenue / Employee
$341,892
Employees
5,967
Market Cap
10.15B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.98B | 12.90M | 0.66% |
Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
QGEN News
- 12 days ago - Qiagen N.V. (QGEN) Presents at Bank of America Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 27 days ago - QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio - Business Wire
- 27 days ago - Qiagen N.V. (QGEN) Presents At Baird Global Healthcare Conference 2025 Prepared Remarks Transcript - Seeking Alpha
- 4 weeks ago - Qiagen N.V. (QGEN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing - Business Wire
- 5 weeks ago - QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds - Business Wire
- 5 weeks ago - QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds - Business Wire
- 5 weeks ago - QIAGEN N.V. Launches Non-US Offering of Net Share Settled Convertible Bonds - Business Wire